期刊文献+

散发性卵巢癌组织中BRCA1蛋白的表达

Expression of BRCA1 protein in sporadic ovarian cancer
下载PDF
导出
摘要 目的 :探讨散发性卵巢癌组织中BRCA1蛋白的表达及其意义。方法 :用免疫组织化学方法检测 4 3例散发性卵巢上皮性癌 (OEC)、10例交界性卵巢上皮性肿瘤和 14例良性卵巢上皮性肿瘤中BRCA1蛋白的表达。结果 :OEC组织中BRCA1的阳性表达率为 39.5 % (17/ 4 3) ,交界性卵巢上皮性肿瘤组织中为 90 .0 % (9/ 10 ) ,良性卵巢上皮性肿瘤组织中为 92 .8% (13/ 14 )。OEC组织中BRCA1蛋白表达阳性率显著低于良性卵巢上皮性肿瘤和交界性卵巢上皮性肿瘤 (P <0 .0 0 5 )。结论 Aim: To investigate the expression of BRCA1 protein in sporadic ovarian cancer and its significance. Methods: The expression of BRCA1 protein in 43 cases of sporadic ovarian cancer,10 cases of borderline epithelial ovarian tumor,and 14 cases of benign epithelial ovarian tumor were detected by immunohistochemistry. Results: BRCA1 positive expression rates were 39.5%(17/43) in sporadic ovarian cancers,90.0%(9/10) in borderline epithelial ovarian tumor, and 92.8%(13/14) in benign epithelial ovarian tumor respectively. The positive expression rate of BRCA1 protein in sporadic ovarian cancers was lower than those in benign and borderline epithelial ovarian tumors ( P <0.005). Conclusion: The reduction of BRCA1 expression may play an important role in the carcinogenesis of sporadic ovarian cancer.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2002年第6期797-799,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目 981170 2 2 2
关键词 散发性卵巢癌 BRCA1蛋白 免疫组织化学 ovarian neoplasm BRCA1 immunohistochemistry
  • 相关文献

参考文献8

  • 1[1]Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCA1 mutations in primary breast and ovarian carcinoma. Science,1994, 266(5 182) : 120
  • 2[2]Chen CF, Li S, Chen Y, et al. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor . J Bio Chem,1996,271 (51) :32 863
  • 3[3]Zheng WX, Luo F, Lu JJ, et al. Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecol Oncol, 2000,76(3) :294
  • 4[4]Fetzer S, Tworek HA, Piver MS, et al. Classification of IVS1-10T→C as a polymorphism of BRCA1. Cancer Genet Cytogenet, 1999,113( 1 ) :58
  • 5[5]Berchuck A, Heron KA, Carney ME, et al. Frequency of germline and somatic BRCA1 mutation in ovarian cancer.Clin Cancer Res, 1998,4(10) :2 433
  • 6[6]Yoshikawa K, Honda K, Inamoto T, et, al. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res,1999,5(6) :1 249
  • 7[7]Baldwin RL,Nemeth E,Tran H, et ,al. BRCA1 promoter region hypermethylation in ovarian carcinoma: a populationbased study. Cancer Res,2000,60(19) :5 329
  • 8[8]Pharoah PD, Easton DF, Stockton DL, et al. Survival in familial BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. Cancer Res, 1999,59 ( 4 ): 868

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部